Skip to content

Effect of zinc on jaundice levels in premature babies

Randomized controlled trial - RCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109419
Enrollment
96
Registered
2026-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E806- Other disorders of bilirubin metabolism

Interventions

Intervention1: Efficacy of zinc sulfate: Efficacy of zinc sulfate on indirect hyperbilirubinemia in preterm infants Intervention2: Zinc Sulfate: Preterm infants with indirect hyperbilirubinemia will r

Sponsors

DR YOGESH GOWDA B G
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All preterm neonates between 32 weeks-36weeks+6days whose bilirubin value comes under phototherapy range in treatment threshold graph in NICE guidelines who are admitted in division of Neonatology, department of Pediatrics, Karnataka Medical college and research institute , Hubballi.

Exclusion criteria

Exclusion criteria: Neonates with direct hyperbilirubinemia, systemic illness, severe sepsis, severe respiratory disease requiring mechanical ventilation, oral intolerance, major gross congenital anomalies (gastrointestinal malformations, heart defects, neural tube defects and with identifiable genetic syndromes), and patients who refused to stay for the study duration were excluded from the study

Design outcomes

Primary

MeasureTime frame
Primary Objective: To compare the reduction of indirect bilirubin values in preterm infants between 32weeks-36weeks+6days with Neonatal hyperbilirubinemia who received zinc supplementation to those who did not Secondary Objective:Reduction in the duration of hospital stay Reduction in duration of phototherapyTimepoint: Primary Objective: To compare the reduction of indirect bilirubin values in preterm infants between 32weeks-36weeks+6days with Neonatal hyperbilirubinemia who received zinc supplementation to those who did not Secondary Objective:Reduction in the duration of hospital stay Reduction in duration of phototherapy

Secondary

MeasureTime frame
Secondary Objective: Reduction in the duration of hospital stay + Reduction in duration of phototherapyTimepoint: Assessed from initiation of treatment until discharge from hospital & completion of phototherapy

Countries

India

Contacts

Public ContactDR SIDDAPPA F DANDINAVAR

KARNATAKA MEDICAL COLLEGE AND RESEARCH INSTITUTE

drsiddufd70@gmail.com9448931892

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026